摘要
急性心肌梗死患病率和病死率高,及时行经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)是急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)患者最佳的再灌注策略。但PCI后出现的冠状动脉无复流常影响着患者的治疗效果和预后。本文针对冠状动脉无复流的病理生理机制、诊断、治疗作一综述,以期找到预防与在临床上解决PCI后冠状动脉无复流的方法。
Due to the high morbidity and mortality of acute myocardial infarction,timely percutaneous coronary intervention(PCI)is the best reperfusion strategy for patients with acute ST-segment elevation myocardial infarction(STEMI).However,the coronary artery no-reflow(CNR)after PCI often affects the therapeutic effect and prognosis of patients.In this paper,the pathophysiological mechanism,diagnosis and treatment of CNR are summarized,so as to find the prevention and clinical solution of CNR after PCI.
作者
芦中林
王宙
李卓然
张静
LU Zhong-lin;WANG Zhou;LI Zhuo-ran;ZHANG Jing(Department of Cardiovascular Medicine,Second Hospital of Jilin University,Changchun 130012,China)
出处
《中国心血管病研究》
CAS
2019年第5期395-398,共4页
Chinese Journal of Cardiovascular Research
关键词
急性心肌梗死
冠状动脉无复流
诊断
治疗
Acute myocardial infarction
Coronary artery no-reflow
Diagnosis
Treatment
